Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Members of the endocannabinoid system are distinctly regulated in inflammatory bowel disease and colorectal cancer
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2019-02-20
DOI
10.1038/s41598-019-38865-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Non-endocannabinoid N -acylethanolamines and 2-monoacylglycerols in the intestine
- (2018) Harald S Hansen et al. BRITISH JOURNAL OF PHARMACOLOGY
- GPCR desensitization: Acute and prolonged phases
- (2018) Sudarshan Rajagopal et al. CELLULAR SIGNALLING
- Medical use of cannabis and cannabinoids containing products – Regulations in Europe and North America
- (2018) Ran Abuhasira et al. European Journal of Internal Medicine
- Combination of APD668, a G protein-coupled receptor 119 agonist with linagliptin, a DPPIV inhibitor, prevents progression of steatohepatitis in a murine model of non-alcoholic steatohepatitis with diabetes
- (2018) Umakant Ashok Bahirat et al. Medical Molecular Morphology
- Lysophosphatidylinositols in inflammation and macrophage activation: Altered levels and anti-inflammatory effects
- (2018) Julien Masquelier et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- The role of CB1 in intestinal permeability and inflammation
- (2017) Mustafa A. Karwad et al. FASEB JOURNAL
- Manipulation of the Endocannabinoid System in Colitis
- (2017) Kristina L. Leinwand et al. INFLAMMATORY BOWEL DISEASES
- G protein-coupled receptor GPR55 promotes colorectal cancer and has opposing effects to cannabinoid receptor 1
- (2017) Carina Hasenoehrl et al. INTERNATIONAL JOURNAL OF CANCER
- Lipidomics by ultrahigh performance liquid chromatography-high resolution mass spectrometry and its application to complex biological samples
- (2017) Alexander Triebl et al. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES
- Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
- (2017) Fernando Magro et al. Journal of Crohns & Colitis
- Prevalence and Patterns of Marijuana Use in Young Adults With Inflammatory Bowel Disease
- (2017) Uma P. Phatak et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Deciphering lipid structures based on platform-independent decision rules
- (2017) Jürgen Hartler et al. NATURE METHODS
- Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis
- (2017) Ester Pagano et al. PHARMACOLOGICAL RESEARCH
- Endocannabinoid system acts as a regulator of immune homeostasis in the gut
- (2017) Nandini Acharya et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion
- (2017) Lorène J. Lebrun et al. Cell Reports
- An update on PPAR activation by cannabinoids
- (2016) Saoirse Elizabeth O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management
- (2016) Fernando Gomollón et al. Journal of Crohns & Colitis
- The gastrointestinal tract - a central organ of cannabinoid signaling in health and disease
- (2016) C. Hasenoehrl et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK
- (2016) Ya-Jing Feng et al. WORLD JOURNAL OF GASTROENTEROLOGY
- An Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse
- (2016) Ester Pagano et al. Frontiers in Pharmacology
- GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis
- (2015) J Kargl et al. BRITISH JOURNAL OF PHARMACOLOGY
- Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis
- (2015) Alexandra Weiss et al. DRUG AND ALCOHOL DEPENDENCE
- The GPR55 antagonist CID16020046 protects against intestinal inflammation
- (2015) A. Stančić et al. NEUROGASTROENTEROLOGY AND MOTILITY
- The Endocannabinoid System and its Modulation by Phytocannabinoids
- (2015) Vincenzo Di Marzo et al. Neurotherapeutics
- Endocannabinoid and ceramide levels are altered in patients with colorectal cancer
- (2015) LING CHEN et al. ONCOLOGY REPORTS
- Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid
- (2014) Francesca Borrelli et al. CARCINOGENESIS
- Cannabis Use Provides Symptom Relief in Patients with Inflammatory Bowel Disease but Is Associated with Worse Disease Prognosis in Patients with Crohnʼs Disease
- (2014) Martin Storr et al. INFLAMMATORY BOWEL DISEASES
- Experimental colitis in mice is attenuated by changes in the levels of endocannabinoid metabolites induced by selective inhibition of fatty acid amide hydrolase (FAAH)
- (2014) M. Sałaga et al. Journal of Crohns & Colitis
- Validating Antibodies to the Cannabinoid CB2 Receptor
- (2014) Yannick Marchalant et al. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
- Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease
- (2013) Francesca Borrelli et al. BIOCHEMICAL PHARMACOLOGY
- Cannabis Induces a Clinical Response in Patients With Crohn's Disease: A Prospective Placebo-Controlled Study
- (2013) Timna Naftali et al. Clinical Gastroenterology and Hepatology
- Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies
- (2013) Alexandra D. Frolkis et al. GASTROENTEROLOGY
- Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation
- (2013) Giuseppe Esposito et al. GUT
- Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease
- (2013) Jessica Ravikoff Allegretti et al. INFLAMMATORY BOWEL DISEASES
- Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
- (2013) Barbara Romano et al. PHYTOMEDICINE
- Implication of the anti-inflammatory bioactive lipid prostaglandin D2-glycerol ester in the control of macrophage activation and inflammation by ABHD6
- (2013) M. Alhouayek et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Regulation of GPR119 receptor activity with endocannabinoid-like lipids
- (2012) Samreen K. Syed et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer
- (2012) Gabriella Aviello et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Topical and Systemic Cannabidiol Improves Trinitrobenzene Sulfonic Acid Colitis in Mice
- (2012) Rudolf Schicho et al. PHARMACOLOGY
- The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity
- (2012) Mireille Alhouayek et al. TRENDS IN MOLECULAR MEDICINE
- GPR119 as a fat sensor
- (2012) Harald S. Hansen et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer
- (2012) CHAN KWON JUNG et al. Oncology Letters
- β-Caryophyllene Inhibits Dextran Sulfate Sodium-Induced Colitis in Mice through CB2 Receptor Activation and PPARγ Pathway
- (2011) Allisson Freire Bento et al. AMERICAN JOURNAL OF PATHOLOGY
- Cannabinoid receptor 2 undergoes Rab5-mediated internalization and recycles via a Rab11-dependent pathway
- (2011) Natasha L. Grimsey et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Agonists at GPR119 mediate secretion of GLP-1 from mouse enteroendocrine cells through glucose-independent pathways
- (2011) H Lan et al. BRITISH JOURNAL OF PHARMACOLOGY
- The L- -Lysophosphatidylinositol/GPR55 System and Its Potential Role in Human Obesity
- (2011) J. M. Moreno-Navarrete et al. DIABETES
- Impact of Cannabis Treatment on the Quality of Life, Weight and Clinical Disease Activity in Inflammatory Bowel Disease Patients: A Pilot Prospective Study
- (2011) Adi Lahat et al. DIGESTION
- Cannabis use amongst patients with inflammatory bowel disease
- (2011) Simon Lal et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Increasing endogenous 2-arachidonoylglycerol levels counteracts colitis and related systemic inflammation
- (2011) Mireille Alhouayek et al. FASEB JOURNAL
- Epidemiology and Natural History of Inflammatory Bowel Diseases
- (2011) Jacques Cosnes et al. GASTROENTEROLOGY
- The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease
- (2011) A Di Sabatino et al. Mucosal Immunology
- N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities
- (2010) Stefania Petrosino et al. BIOCHIMIE
- Inflammation and Colon Cancer
- (2010) Janoš Terzić et al. GASTROENTEROLOGY
- The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
- (2010) William R Marrs et al. NATURE NEUROSCIENCE
- Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI
- (2009) Alain M Schoepfer et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Role of acylethanolamides in the gastrointestinal tract with special reference to food intake and energy balance
- (2009) Francesca Borrelli et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- Activation of the cannabinoid 2 receptor (CB2) protects against experimental colitis
- (2009) Martin A. Storr et al. INFLAMMATORY BOWEL DISEASES
- Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon
- (2009) Antonietta Santoro et al. INTERNATIONAL JOURNAL OF CANCER
- Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis
- (2009) Francesca Borrelli et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue
- (2009) Lucia Marquéz et al. PLoS One
- Cannabinoid receptor-independent cytotoxic effects of cannabinoids in human colorectal carcinoma cells: synergism with 5-fluorouracil
- (2008) Sofia B. Gustafsson et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Loss of Cannabinoid Receptor 1 Accelerates Intestinal Tumor Growth
- (2008) D. Wang et al. CANCER RESEARCH
- 2-Arachidonoyl-sn-glycero-3-phosphoinositol: A Possible Natural Ligand for GPR55
- (2008) S. Oka et al. JOURNAL OF BIOCHEMISTRY
- Lipid extraction by methyl-tert-butyl ether for high-throughput lipidomics
- (2008) Vitali Matyash et al. JOURNAL OF LIPID RESEARCH
- Specific detection of CB1 receptors; cannabinoid CB1 receptor antibodies are not all created equal!
- (2008) Natasha L. Grimsey et al. JOURNAL OF NEUROSCIENCE METHODS
- Beta-caryophyllene is a dietary cannabinoid
- (2008) Jürg Gertsch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The orphan receptor GPR55 is a novel cannabinoid receptor
- (2007) E Ryberg et al. BRITISH JOURNAL OF PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started